The preparation of HL-60 cells vaccine expressing BCG heat shock protein 70 and detection of its immunogenicity in vitro

References

• Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008; 371:1030 - 43; http://dx.doi.org/10.1016/S0140-6736(08)60457-2; PMID: 18358930
   PubMed Web of Science ®Google Scholar
• Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29:551 - 65; http://dx.doi.org/10.1200/JCO.2010.30.7405; PMID: 21220611
   PubMed Web of Science ®Google Scholar
• Stow P, Key L, Chen X, Pan Q, Neale GA, Coustan-Smith E, et al. Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. Blood 2010; 115:4657 - 63; http://dx.doi.org/10.1182/blood-2009-11-253435; PMID: 20304809
   PubMed Web of Science ®Google Scholar
• Yang J, Sun LR, Pang XY, Lu Y, Li XR, Song AQ. [Effect of Bacillus Calmette-Guerin on the expansion of dendritic cells from peripheral blood of pediatric patients with leukemia in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18:1240 - 3; PMID: 21129268
   PubMedGoogle Scholar
• Peng ML, Chen M, Ling N, Xu H, Qing Y, Ren H. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70. Vaccine 2006; 24:887 - 96; http://dx.doi.org/10.1016/j.vaccine.2005.12.050; PMID: 16446013
   PubMed Web of Science ®Google Scholar
• Wei MQ, Mengesha A, Good D, Anné J. Bacterial targeted tumour therapy-dawn of a new era. Cancer Lett 2008; 259:16 - 27; http://dx.doi.org/10.1016/j.canlet.2007.10.034; PMID: 18063294
   PubMed Web of Science ®Google Scholar
• Ye J, Chen GS, Song HP, Li ZS, Huang YY, Qu P, et al. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo. Cancer Immunol Immunother 2004; 53:825 - 34; http://dx.doi.org/10.1007/s00262-004-0536-6; PMID: 15127237
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li ZJ, Ma ZH, Chen X, Pan XY, Zhang FC. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000; 60:1025 - 42
   Google Scholar
• Onishi H, Kuroki H, Matsumoto K, Baba E, Sasaki N, Kuqa H. Monocyte-derived dendritic cells that capture dead tumor cells secret IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. J Cancer Immunol Immunother 2004; 53:1093 - 100; http://dx.doi.org/10.1007/s00262-004-0568-y
   PubMed Web of Science ®Google Scholar
• Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Rice CM, et al. Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene. J Immunol 2001; 166:6218 - 26; PMID: 11342644
   PubMed Web of Science ®Google Scholar
• Hsu KF, Hung CF, Cheng WF, He L, Slater LA, Ling M, et al. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther 2001; 8:376 - 83; http://dx.doi.org/10.1038/sj.gt.3301408; PMID: 11313814
   PubMed Web of Science ®Google Scholar
• June CH. Adoptive T cell therapy for cancer in the clinic. J Clin Invest 2007; 117:1466 - 76; http://dx.doi.org/10.1172/JCI32446; PMID: 17549249
   PubMed Web of Science ®Google Scholar
• Ahmad M, Rees RC, Ali SA. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother 2004; 53:844 - 54; http://dx.doi.org/10.1007/s00262-004-0540-x; PMID: 15197495
   PubMed Web of Science ®Google Scholar
• Rouas-Freiss N, Moreau P, Menier C, LeMaoult J, Carosella ED. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin Cancer Biol 2007; 17:413 - 21; http://dx.doi.org/10.1016/j.semcancer.2007.07.003; PMID: 17881247
   PubMed Web of Science ®Google Scholar
• Peng ML, Chen M, Ling N, Xu H, Qing Y, Ren H. Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70. Vaccine 2006; 24:887 - 96; http://dx.doi.org/10.1016/j.vaccine.2005.12.050; PMID: 16446013
   PubMed Web of Science ®Google Scholar
• Mizukami S, Kajiwara C, Ishikawa H, Katayama I, Yui K, Udono H. Both CD4+ and CD8+ T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors. Cancer Sci 2008; 99:1008 - 15; http://dx.doi.org/10.1111/j.1349-7006.2008.00788.x; PMID: 18341654
   PubMed Web of Science ®Google Scholar
• Murshid A, Gong J, Calderwood SK. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev Vaccines 2008; 7:1019 - 30; http://dx.doi.org/10.1586/14760584.7.7.1019; PMID: 18767951
   PubMed Web of Science ®Google Scholar
• Yamaoka A, Guan X, Takemoto S, Nishikawa M, Takakura Y. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system. J Control Release 2010; 142:411 - 5; http://dx.doi.org/10.1016/j.jconrel.2009.11.005; PMID: 19913062
   PubMed Web of Science ®Google Scholar
• Hockertz S. Present and future of cancer vaccines. Toxicology 2005; 214:151 - 61; http://dx.doi.org/10.1016/j.tox.2005.06.004; PMID: 16259078
   PubMed Web of Science ®Google Scholar
• Venken K, Thewissen M, Hellings N, Somers V, Hensen K, Rummens JL, et al. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 2007; 322:1 - 11; http://dx.doi.org/10.1016/j.jim.2007.01.025; PMID: 17368474
   PubMed Web of Science ®Google Scholar
• Tsuge I, Okumura A, Kondo Y, Itomi S, Kakami M, Kawamura M, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149 - 55; http://dx.doi.org/10.2332/allergolint.O-06-457; PMID: 17460442
   PubMedGoogle Scholar
• Placek K, Coffre M, Maiella S, Bianchi E, Rogge L. Genetic and epigenetic networks controlling T helper 1 cell differentiation. Immunology 2009; 127:155 - 62; http://dx.doi.org/10.1111/j.1365-2567.2009.03059.x; PMID: 19476511
   PubMed Web of Science ®Google Scholar
• Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia. Ann Hematol 1995; 70:153 - 8; http://dx.doi.org/10.1007/BF01682036; PMID: 7718644
   PubMed Web of Science ®Google Scholar
• Piriou L, Chilmonczyk S, Genetet N, Albina E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 2000; 41:289 - 97; http://dx.doi.org/10.1002/1097-0320(20001201)41:4<289::AID-CYTO7>3.0.CO;2-5; PMID: 11084614
   PubMedGoogle Scholar